Interessanti aggiornamenti dall’Europa e dal Mondo rispettivamente da ESOP e ISOPP.
La società europea di farmacia oncologica, ESOP, ha aperto le abstract submission.
Questi i riferimenti dell’evento:
ECOP 5 conference postponed to November 2021!
https://esop.li/ecop/. We would like to inform you that due to the Corona virus outbreak the European Society of Oncology Pharmacy (ESOP) has made an uneasy decision to postpone the ECOP 5 conference, which was scheduled for 5 – 7 November 2020 in Malta. We are concerned about your health and we want to do our part to keep everyone safe. The conference instead will be held at the same venue on 25-27 November 2021 in Malta. We hope that you remain healthy and stay safe during these challenging times.
La società internazionale di farmacia oncologica, ISOPP, ha recentemente pubblicato un nuovo interessante position statement. Questi i riferimenti:
ISOPP Position Statement: Role of the Oncology Pharmacy Team in Cancer Care
The ISOPP Credentialing, Specialization, Scope of Practice Task Force has created a position statement to describe the roles of oncology pharmacists and technicians in cancer patient care. Creating this position statement aligns with ISOPP’s strategic goals to engage members around the world to advance oncology pharmacy practice and to provide information that promotes advocacy, especially for countries where the profession has not yet recognized oncology pharmacy as a specialty.
Read it now by clicking HERE. The Statement will be published in JOPP. Thank you for your support in advancing oncology pharmacy practice and to all who have contributed to the Position Paper.
